Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests airflow device vs curette for implant gum disease

NCT ID NCT06849856

Disease control Sponsor: Hacettepe University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two non-surgical treatments for peri-implantitis, a gum disease that affects dental implants. Thirty-eight adults with deep gum pockets around their implants received either a titanium curette, an airflow device with erythritol powder, or both. Researchers measured gum pocket depth, bleeding, and biomarkers in the gum fluid over 6 months to see which approach works best.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
airflow device with erythritol powder and titanium curette
What this could lead to
If successful, this could point toward a more effective non-surgical treatment for peri-implantitis, potentially improving gum health and reducing bone loss around dental implants.
What could go wrong
This is a small, completed study with only 38 participants, so results may not apply to everyone. The treatments are compared for short-term outcomes (6 months), and long-term benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

38 people

The number who actually took part.

Started

Dec 2023

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Who have not received any periodontal treatment in the last 6 months, 2. Who have not used any medication (antibiotics, anti-inflammatory drugs, antibacterial mouthwashes, corticosteroids) that could affect the results of the study in the last 3 months, 3. Who have at least one implant with a probing depth of 6 mm or deeper in one or more areas in the mouth, and the implant in question has been in function for at least 1 year, 4. Between the ages of 18-65, 5. Individuals who approve the informed consent form will be included in the study. Exclusion Criteria: Individuals who: 1. have a systemic disease that may affect the periodontium, 2. regularly use medication that may affect the periodontium, 3. smoke, 4. are pregnant or lactating, 5. are sensitive to chlorhexidine, 6. have more than 50% bone loss around their current implant(s), 7. do not approve the informed consent form will be excluded from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Periimplantitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Peri-Implantitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Periimplantitis

Contacts and locations

Locations

  • Hacettepe University

    Ankara, 06100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.